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Abstract
Background:  Most epidemiological studies of major depression report period prevalence
estimates. These are of limited utility in characterizing the longitudinal epidemiology of this
condition. Markov models provide a methodological framework for increasing the utility of
epidemiological data. Markov models relating incidence and recovery to major depression
prevalence have been described in a series of prior papers. In this paper, the models are extended
to describe the longitudinal course of the disorder.
Methods: Data from three national surveys conducted by the Canadian national statistical agency
(Statistics Canada) were used in this analysis. These data were integrated using a Markov model.
Incidence, recurrence and recovery were represented as weekly transition probabilities. Model
parameters were calibrated to the survey estimates.
Results: The population was divided into three categories: low, moderate and high recurrence
groups. The size of each category was approximated using lifetime data from a study using the
WHO Mental Health Composite International Diagnostic Interview (WMH-CIDI). Consistent with
previous work, transition probabilities reflecting recovery were high in the initial weeks of the
episodes, and declined by a fixed proportion with each passing week.
Conclusion: Markov models provide a framework for integrating psychiatric epidemiological data.
Previous studies have illustrated the utility of Markov models for decomposing prevalence into its
various determinants: incidence, recovery and mortality. This study extends the Markov approach
by distinguishing several recurrence categories.
Introduction
In a series of previous reports, we have described the use
of Markov models in major depression epidemiology. In
two initial papers, we described a general approach to
modeling, in which prevalence was depicted as a steady
state outcome of inflow and outflow from a prevalence
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pool [1,2]. Subsequently, the approach was extended to
include strata for age and sex categories [3], other demo-
graphic variables [4] and chronic conditions [5]. Broadly
speaking, Markov models are useful for medical decision
modeling and economic analyses. In the case of major
depression, many of the most important health policy
decisions relate to the longitudinal course of the condi-
tion. Clinical practice guidelines, for example, frequently
distinguish between high recurrence and low recurrence
groups, subjects with a high risk of recurrence being can-
didates for long-term treatment. In this report, we
describe an application of Markov modeling to descrip-
tion of the longitudinal course of major depression.
Markov models are important in this context because the
current literature presents few other options for modeling.
To our knowledge, the only other example of an epidemi-
ological general population model is that reported by Kru-
ijshaar et al. [6] using microsimulation. This study
integrated data from European (NEMESIS) [7] and Aus-
tralian studies [8]. The use of more than one data source
in this study illustrates the potential usefulness of mode-
ling as a means of integrating the best available epidemi-
ological data into a coherent epidemiological description.
For purposes such as surveillance, policy development
and cost-effectiveness analysis, data integration using epi-
demiological modeling is a promising approach.
Markov models, also known as health state transition
models, divide a target population into a series of mutu-
ally exclusive health states. Transitions between these
health states are assigned probabilities and the model's
predictions are evaluated over a series of stages [9].
Data Sources
In a series of previous reports, we used data from a Cana-
dian study called the National Population Health Survey
(for additional information about the NPHS; see, http://
www.statcan.ca/english/concepts/nphs/nphs.htm) to
model the relationship between prevalence, incidence
and mortality. The longitudinal component of the NPHS
uses a nationally representative probability sample ini-
tially consisting of 17,262 subjects who have subse-
quently been followed through four biannual data
collection cycles. The NPHS provides a valuable source of
longitudinal health data. A limitation, however, is that the
NPHS utilized only a brief predictive instrument for major
depression, the Composite International Diagnostic Inter-
view Short Form [10] for Major Depression (CIDI-SFMD).
This instrument identifies subjects with a high probability
of having met DSM-IV [11] criteria for major depression
in the preceding year, but does not provide fully specified
data about recurrence. The CIDI-SFMD instrument covers
only one half (12 months) of the interval between NPHS
interviews (conducted 24 months apart). The CIDI Short
Form only covers the final 12 months of this 24-month
interval. The proportion of subjects without major depres-
sion at one interview who have an episode at the next
interview can be directly estimated from the NPHS data,
but this estimate provides only an approximation of the
annual incidence proportion.
The CIDI-SFMD also includes an item that assesses epi-
sode duration. This item elicits the number of weeks dur-
ing the previous year that a subject with CIDI-SFMD
major depression was depressed. Notably, the number of
weeks depressed during the preceding year only precisely
assesses episode duration in subjects whose episode
began and ended within that year. A final limitation of the
NPHS is its sample size. Although the longitudinal cohort
was relatively large, the number of subjects with major
depressive episodes during any particular interview cycle
was small enough to result in appreciable imprecision in
estimating the weeks depressed in the past year variable.
Fortunately, Statistics Canada conducted a related survey,
called the Canadian Community Health Survey (CCHS
1.1) http://www.statcan.ca/english/concepts/health/
cchsinfo.html during the same time frame and using the
same sampling frame and which also included the CIDI-
SFMD. The CCHS 1.1 had a sample size of 130,880 sub-
jects, and therefore offered much greater precision for esti-
mating episode duration.
In order to estimate the proportion of the population fall-
ing into various recurrence categories, neither of the two
data sources listed above were adequate. The NPHS, as
noted, provides incomplete longitudinal follow-up and
the CCHS 1.1 was strictly cross-sectional. In Canada, the
best source of lifetime data is the Canadian Study of Men-
tal Health and Wellbeing, also known as the CCHS 2.1
http://www.statcan.ca/english/sdds/3226.htm. This study
used the same sampling frame as the other two, but eval-
uated major depression using the World Health Organiza-
tion's Mental Health (WMH2000) project WMH-CIDI
[12]. This instrument provided a basis for dividing the
population into three broad categories of recurrence risk
based on the pattern of recurrence reported by the CIDI.
Subjects with no prior episodes of major depression (low
risk of developing an episode), those having had one epi-
sode (moderate risk) and with multiple prior episodes
(high risk).
Approach to Markov Modeling
The Markov models developed here adopted the general
format of an incidence-prevalence model, modeling the
"prevalence pool" [13] for major depression as a function
of the inflow to the pool (incidence and recurrence) and
the outflow through recovery. For simplicity, mortality
was not included in the models presented here since our
previous work indicated that this variable did not have anPopulation Health Metrics 2005, 3:11 http://www.pophealthmetrics.com/content/3/1/11
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important influence on the epidemiological dynamics [1].
Changes in health state (depressed and not-depressed)
were evaluated over a series of one week stages. To deal
with declining probabilities of recovery with mounting
episode length, a Markov tunnel [9] was used to depict the
process of recovery. The Markov tunnel is a way of adding
flexibility to a Markov model. The Markov tunnel used in
this model consisted of a series of depressed health states,
so that at the onset of an episode (by definition at 2-weeks
after the onset of symptoms) the subject occupies a health
state that represents the first week in an episode. At the
next stage, there can be a transition either to the non-
depressed state or, alternatively, the subject can progress
into a health state representing the next week of the epi-
sode. By selecting transitions back to the non-depressed
health state that decline with each stage in the tunnel, the
pattern of recovery can be flexibly depicted.
As noted above, it was not possible to directly estimate
incidence and episode duration from the available data
sources. Using tracking variables in the Markov model, it
was, however, possible to define variables depicting
parameters that are directly estimable: the proportion
without an episode at one interview with an episode in
the year prior to a subsequent interview and weeks
depressed in the past year. The Markov models could then
be evaluated by Monte Carlo simulation across a series of
possible values for incidence and recovery to find the val-
ues most consistent with the observed estimates. The
model is presented in Figure 1. The population is depicted
Framework for the Markov Model Employed in the Project, Depicting Three Recurrence Strata Figure 1
Framework for the Markov Model Employed in the Project, Depicting Three Recurrence Strata.
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in three strata, with size of the strata fixed according to the
CCHS 1.2 results.
Estimation from the Epidemiological Data 
Sources
Data from the three source studies were employed as
described above: the NPHS to calibrate the transition
probabilities for episode incidence, the CCHS 1.1 for
weeks depressed in past year data and the CCHS 1.2 for
the lifetime recurrence pattern. The sample sizes for the
three studies were: 17,262 (at baseline), 130,880 and
36,525, respectively. Each survey used the same complex
sampling frame. All reported estimates incorporated sam-
pling weights and appropriate statistical procedures to
deal with the resulting design effects. The estimates were
made using SAS Version 8.1.
Monte Carlo Simulation
The simulation period was set at 312 weeks (i.e. 6 years)
in order to depict the duration of data available from the
NPHS (data from the first four cycles, 1994 to 2000, had
been released at the time when the analysis was con-
ducted). Each simulation used 50,000 Monte Carlo trials
to reduce random variation in the simulation output.
Tracker variables were used to link the model output to
directly estimable parameters, as described above.
Cumulative Distribution of Reported Number of Weeks Depressed in Past Year, Subjects with CIDI-SFMD Major Depressive  Episode Figure 2
Cumulative Distribution of Reported Number of Weeks Depressed in Past Year, Subjects with CIDI-SFMD Major Depressive 
Episode.
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A single Markov tunnel was used to describe the recovery
pattern in each of the three incidence/recurrence risk cat-
egories. Essentially, this represents an assumption that
episode prognosis is similar in the various recurrence cat-
egories. Successive Monte Carlo simulations were used to
identify values for weekly incidence within each category
that could explain both the observed overall incidence
and duration data, as well as the pattern of recurrence
observed over the six year NPHS follow-up period (the
proportions of subjects having one, two or three detected
episodes).
Results
In the NPHS, the estimated proportion of the population
without major depression at baseline who had one or
more episodes during the subsequent six years (keeping in
mind that the three interviews conducted during the six
year follow-up period only covered three of these six
years) was 9.3%. Of this population, 7.8% had one epi-
sode, 1.3% had two episodes and 0.3% had three episodes
(these add to 9.4% due to approximation in rounding).
The latter group represented those subjects who were pos-
itive on the CIDI-SFMD at each of the three follow-up vis-
its. Some of these CIDI-SFMD positive instances may have
represented persistence rather than recurrence, a distinc-
tion that could not be made using the NPHS data set.
According to data from the CCHS 1.2, the lifetime preva-
lence of major depression in the Canadian general popu-
lation is 12.2% (95% C.I. 11.7% – 12.7%), consistent
with European estimates [14] and somewhat less than
American [15] estimates using the WMH2000 CIDI
instrument. In the NPHS, 12.5% of the subjects had an
episode at one or more of the follow-up interviews.
Observed and Simulated Proportions in NPHS Recurrence Categories Figure 3
Observed and Simulated Proportions in NPHS Recurrence Categories.
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The pattern for "number of weeks depressed" for subjects
reporting an episode of major depression is presented as a
cumulative proportion in Figure 2. Consistent with exist-
ing literature, many subjects had brief episodes, but as
expected, the pattern suggested a declining probability of
recovery with increasing episode duration. For example,
the difference between the proportion of the population
reporting  n  weeks depressed in the past year and n+1
weeks depressed in the past year became smaller as n
became larger.
As expected, the use of higher values for the incidence and
recurrence resulted in a larger proportion of subjects with
recurrent episodes. Because the proportions falling into
the moderate and high recurrence groups were con-
strained by the CCHS 1.2 estimates, it was possible to
identify, using a series of simulations, values for incidence
within each recurrence category that resulted in the pat-
tern observed in the NPHS. Figure 3 presents observed
and simulated recurrence data for the parameters selected;
Figure 4 is a depiction of the model, including values for
the transition probabilities. Weekly transition probabili-
ties were 0.00028 per week in the low risk, 0.0010 per
week in the moderate risk and 0.00575 in the high risk
categories.
The Markov tunnel describing the weekly recovery proba-
bilities (pr) followed the pattern of pr = 0.18*e-0.09*week so
that the probability of recovery was initially very high, but
declined by approximately 9% with each week spent in
the depressed state. The tunnel was truncated after 26
weeks, such that the probability of recovery once one half
of a year was spent in the depressed state remained con-
stant at approximately one half of one percent per week.
Figure 5 juxtaposes the observed and simulated number
of weeks depressed in the past year.
Specifications for the Markov Model Figure 4
Specifications for the Markov Model.
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For ease of interpretation, it is possible to express the
weekly transition probabilities as an expected annual
cumulative incidence for depression using the formula:
annual cumulative incidence = 1 - (1-weekly transition
probability)52. Using this formula, the annual incidence
in the low, moderate and high recurrence categories are:
1.4%, 5.1% and 25.9%. The weighted overall annual inci-
dence is 3.3%, consistent with existing literature [16]. The
mean number of weeks spent in the depressed state was
estimated by Monte Carlo simulation in those with a sin-
gle episode over the 312 week simulation interval, and
was found to be 16.8 weeks (median = 9.0 weeks). These
results are broadly consistent with the literature, where a
range for mean duration of 12 to 30 weeks has been
reported [17]. The considerable difference between
median and mean duration has also been reported [18],
and reflects the very long duration of a minority of epi-
sodes. Additional File 1 is the Markov model in the form
of a Treeage® Data Pro file, the Markov tunnel is contained
in Additional File 2.
Discussion
The model presented here projects a 9.3% overall new-
episode frequency over a period of 6 years. Intuition sug-
gests that since the duration of follow-up in the NPHS was
essentially 6 years, lifetime prevalence should considera-
bly exceed the observed occurrence of one or more epi-
sodes in the NPHS. This was not found to be the case,
since lifetime prevalence from the CCHS 1.2, which used
the WMH-CIDI was only 12.2%. This may be due to a lack
of specificity of the CIDI-SFMD [19], which could bias the
NPHS-derived incidence and prevalence estimates
upwards. It is also possible that recall bias affected the
WMH-CIDI lifetime prevalence estimate, which could
bias the lifetime prevalence estimate downward. This
interpretation is consistent with Kruijshaar et al.'s micro-
Observed and Simulated Weeks Depressed in the Past Year Figure 5
Observed and Simulated Weeks Depressed in the Past Year.
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simulation results, which suggested that lifetime preva-
lence may actually be 20–30% [6] and is also consistent
with the observation that approximately 50% of episodes
are forgotten after a 25 year period [20]. Many previous
authors have speculated that recall bias may result in
underestimation of lifetime prevalence [21-23].
Since lifetime data from the WMH-CIDI were used to cal-
ibrate the Markov model presented here, and since the
Kruijshaar et al. [6] microsimulation model suggested that
recall bias may impact upon such estimates, the Markov
model presented here may have been calibrated against an
imperfect standard. Since recall bias would probably have
the largest impact on remote episodes, the impact on our
Markov model would probably be an underestimation of
the proportion of the population in the low recurrence
categories. In the future, studies with longer-term follow-
up will be helpful for clarifying these dynamics more deci-
sively.
Another limitation of these data was the assumption that
the three categories identified by the CCHS 1.2 repre-
sented the proportion of the population falling into three
broad recurrence categories. Subjects with no lifetime
major depression were used to approximate the size of a
low-risk category in the population, single episodes a
moderate risk category and multiple episodes a high risk
category. This division was somewhat arbitrary, but
needed to be adopted because the NPHS data was also
used to estimate incidence (it would have been tautologi-
cal to estimate incidence from the same proportions that
defined recurrence risk).
Figure 4 presents a more advanced Markov-based frame-
work describing major depression epidemiology than pre-
viously described Markov models, and the model appears
to provide a good description of available Canadian
major depression data, despite the specified limitations.
To our knowledge, such a method for estimating inci-
dence and recurrence of major depression has not been
previously reported. Markov models are commonly used
in cost-effectiveness modeling (e.g. see, Sorensen et al.
[24]). More recently, integration of data from psychiatric
epidemiological surveys and clinical trials for cost-utility
analyses has been described [25,26]. While available
modeling approaches have limitations, they do provide a
methodological framework which should support
increasingly meaningful descriptions of major depression
epidemiology. Of most importance, it should be possible
to refine these models since they provide a platform for
integrating the best available information as this becomes
available.
Disclaimer
The analyses reported here are based on data collected by
Statistics Canada http://www.statcan.ca, but do not repre-
sent the opinions or interpretations of Statistics Canada.
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